Updated report on identification of molecular predictors of tazemetostat response in an ongoing NHL phase 2 study
McDonald, A Thomas, E Daigle, S Morschhauser, F Salles, G Ribrag, V Mckay, P Tilly, H Schmitt, A Batlevi, CL
McDonald, A
Thomas, E
Daigle, S
Morschhauser, F
Salles, G
Ribrag, V
Mckay, P
Tilly, H
Schmitt, A
Batlevi, CL
Citations
Altmetric:
Abstract
Authors
McDonald, A
Thomas, E
Daigle, S
Morschhauser, F
Salles, G
Ribrag, V
Mckay, P
Tilly, H
Schmitt, A
Batlevi, CL
Fruchart, C
Johnson, P
Dickinson, M
Opat, S
Jurczak, W
Cartron, G
Lamy, T
Zinzani, L
Assouline, S
Radford, John A
Gribben, G
Haioun, C
Chaidos, A
Le Gouill, S
Clawson, A
Larus, J
Blakemore, J
Thomas, E
Daigle, S
Morschhauser, F
Salles, G
Ribrag, V
Mckay, P
Tilly, H
Schmitt, A
Batlevi, CL
Fruchart, C
Johnson, P
Dickinson, M
Opat, S
Jurczak, W
Cartron, G
Lamy, T
Zinzani, L
Assouline, S
Radford, John A
Gribben, G
Haioun, C
Chaidos, A
Le Gouill, S
Clawson, A
Larus, J
Blakemore, J
Affiliation
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
McDonald A, Thomas E, Daigle S, Morschhauser F, Salles G, Ribrag V, et al.Updated report on identification of molecular predictors of tazemetostat response in an ongoing NHL phase 2 study. Blood. 2018;132.